The Buzz of BIO contest provides an excellent opportunity for companies looking to make the connections needed to take their product to the next phase. Ten biotechs will be nominated in each of the three categories: Early Stage Entrepreneurs, Late Stage Leaders, and Diagnostics and Beyond. The companies with the most number of votes in each category at the end of the voting period will win a complimentary conference registration and company presentation, along with exposure to thousands of industry elites and potential investors. Please note that the contest is open to U.S. companies only.
To qualify for the Early Stage Entrepreneur Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised less than $25 million USD as of July 1, 2019; have been founded after 2016; and have most recently completed either a Seed or Series A financing round. Companies that have previously presented at the BIO Investor Forum are not eligible for the Early Stage Entrepreneur category but are welcome to apply under the Late Stage Leader category (if the company meets the minimum dollar requirements of the Late Stage Leader category).
To qualify for the Late Stage Leader Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised more than $25 million USD as of July 1, 2019 and have enrolled at least one patient in a company-sponsored clinical trial posted at https://clinicaltrials.gov/.
To qualify for the Diagnostics and Beyond category, companies must be primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies.
Read the official contest rules here.